January 12, 2011
In this 2011 video, Dr. Trotter talks about the CAP melanoma protocol for cancer staging and patient prognosis
Watch as Dr. Martin Trotter talks about the CAP protocol for skin cancer, including staging and prognosis. He also talks about the changes made since the last checklist, the uncertainties around reporting with this checklist and reporting the sentinel lymph node biopsy as part of the protocol.
Martin Trotter, MD, PhD, is the Department Head of the Pathology and Laboratory Medicine Department at Providence Health Care in Vancouver, British Columbia (BC), Canada. He attended UBC and trained in Dermatopathology in London, England. He’s practised pathology in both Vancouver, BC and Calgary, Alberta. At the University of Calgary and Calgary Laboratory Services, he was the Division Head of Anatomic Pathology and Cytopathology and directed the Immunohistochemistry laboratory. He served as acting academic Department Head in 2004. Dr. Trotter was the President of the Canadian Association of Pathologists from 2013 to 2015.
Watch the video for the CAP education session from 2011 about skin cancer
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.